• Paroxetine Does Not Alter Thiothixene Pharmacokinetics in Hu

  2026-04-22

  This pivotal study demonstrates that short-term paroxetine pretreatment does not significantly impact the pharmacokinetics of thiothixene, a typical antipsychotic agent. The findings clarify the metabolic independence of thiothixene from CYP2D6, informing safer co-administration in psychotic disorder therapy and experimental workflows.

• Astragaloside IV Protects Diabetic Hearts via TLR4/MyD88/NF-

  2026-04-22

  This study demonstrates that astragaloside IV attenuates inflammation and apoptosis in diabetic cardiomyopathy by inhibiting the TLR4/MyD88/NF-κB signaling pathway. The findings highlight a mechanistic link between TLR4-driven inflammation and diabetic cardiac injury, suggesting new experimental strategies for modulating inflammatory signal pathways in metabolic heart disease.

• Macrolide Antibiotics as Senolytics: Azithromycin and Roxith

  2026-04-21

  The referenced study identifies Azithromycin and Roxithromycin as a new class of senolytic agents capable of selectively eliminating senescent human fibroblasts, distinguishing them from structurally related antibiotics like Erythromycin. This discovery expands the potential of clinically approved macrolide antibiotics beyond antibacterial activity, offering novel avenues for research into aging, cellular senescence, and drug repurposing.

• Strategic Advances with Toremifene Citrate in Breast Cancer

  2026-04-21

  This thought-leadership article explores Toremifene Citrate as an oral selective estrogen receptor modulator (SERM), detailing its mechanistic action, strategic application in translational breast cancer research, comparative clinical outcomes, and forward-looking experimental recommendations. Integrating current literature and APExBIO’s product specifications, the piece bridges molecular insight with actionable guidance for researchers seeking to advance estrogen receptor signaling studies.

• EPZ-6438: Precision EZH2 Inhibition for Advanced Cancer Epig

  2026-04-20

  Explore how EPZ-6438, a potent EZH2 inhibitor, is revolutionizing epigenetic cancer research by enabling precise modulation of chromatin marks and gene expression. This in-depth article uniquely dissects its application in HPV-associated tumors and beyond.

• Sisomicin: Comparative Antibacterial Activity and Clinical U

  2026-04-20

  This review by Paul Noone systematically evaluates the antibacterial spectrum, resistance profiles, and pharmacokinetics of Sisomicin, Netilmicin, and Dibekacin. Key findings highlight Sisomicin’s potent activity against Gram-negative pathogens, its mechanistic parallels and distinctions relative to gentamicin and tobramycin, and its therapeutic implications for resistant infections.

• Phosbind Biotin: Elevating Western Blot Phosphorylation Anal

  2026-04-19

  Phos binding reagent (Phosbind) Biotin harnesses dinuclear metal complex phosphate binding to unlock sequence-independent, high-sensitivity detection of phosphorylated proteins in Western Blot workflows. This reagent empowers rapid, antibody-free analysis of post-translational modifications, fueling breakthrough insights in plant stress and signal transduction research.

• Estradiol-ERα Axis Restores CD4+ T Cell Function After Hemor

  2026-04-18

  This study demonstrates that 17β-estradiol (E2) restores splenic CD4+ T lymphocyte proliferation and cytokine production following hemorrhagic shock via estrogen receptor-α (ERα)-mediated inhibition of endoplasmic reticulum stress (ERS). The findings highlight the mechanistic basis for immune modulation after trauma and inform future endocrine therapy resistance and immunomodulation research.

• 2-APB: Precision Control of Calcium Signaling in Cell Fate R

  2026-04-17

  Explore how 2-APB (2-aminoethoxydiphenyl borate) empowers translational researchers to dissect ER-Ca2+-calpain signaling in programmed cell death. This article synthesizes mechanistic insight and strategic guidance, referencing the latest Bombyx mori study and benchmarking APExBIO’s reagent against competitive tools for autophagy, apoptosis, and oxidative stress research.

• Single-Nucleus Transcriptomics Reveals ATRNL1's Role in AF

  2026-04-16

  This study applies large-scale single-nucleus RNA sequencing to human atrial tissue, identifying ATRNL1 as a key regulator in atrial fibrillation (AF) through cell-type specific expression changes. The findings advance the molecular understanding of AF and highlight therapeutic targeting potential in cardiac arrhythmias.

• Synergistic Apoptosis and Pyroptosis via Caspase-8 in Hypert

  2026-04-15

  The referenced study uncovers a novel mechanism where hyperthermia and cisplatin co-treatment enhances tumor cell death by promoting caspase-8 accumulation, K63-linked polyubiquitination, and downstream activation of apoptotic and pyroptotic pathways. These findings provide mechanistic insight into the synergy between hyperthermia and chemotherapy, supporting advanced immunodetection strategies for translational cancer research.

• HDAC Inhibitors as NUT Carcinoma Repressors: Mechanisms and

  2026-04-14

  Shiota et al. conducted a comprehensive chemical screen to identify inhibitors of NUT function in NUT carcinoma, revealing that diverse histone deacetylase (HDAC) inhibitors effectively repress oncogenic transcriptional programs. This work uncovers a mechanistic link between chromatin acetylation dynamics and NUT carcinoma pathology, highlighting HDAC inhibition as a potential therapeutic avenue.

• Elobixibat Hydrate: Optimizing IBAT Inhibition Workflows

  2026-04-13

  Elobixibat hydrate empowers researchers to model bile acid transport, gut motility, and metabolic regulation with superior selectivity and reproducibility. This article details applied use-cases, protocol parameters, and troubleshooting strategies to maximize experimental success, drawing on APExBIO’s trusted supply and latest translational insights.

• Starvation-Induced Autophagy-Apoptosis Switch via ER-Ca2+-Ca

  2026-04-13

  This study elucidates how starvation drives a transition from autophagy to apoptosis in Bombyx mori fat body cells, mediated by ER-Ca2+-calpain signaling. The findings highlight the central role of IP3R-mediated calcium dynamics and demonstrate that 2-APB effectively suppresses both autophagic and apoptotic responses under nutrient stress.

• Phenothiazines Boost Macrophage Antibacterial Action via ROS

  2026-04-12

  This study demonstrates that phenothiazines, including key dopamine receptor antagonists, enhance the antibacterial capacity of macrophages by inducing reactive oxygen species (ROS) generation and autophagy. These findings provide a mechanistic basis for repurposing phenothiazine compounds in host-directed therapies against intracellular bacterial infections.

15279 records 1/1019 page Next 12345 下5页 Last page